Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Manar M. Kandil

Manar M. Kandil


Clinical Assistant Professor, Pharmacy Practice

Teaching and Supervision Heading link

PHAR 414: IPPE – Introduction to Patient Care (PHAR 414), 3/1/2023 – Present
PHAR 502: PDAT 2 – GI/Endocrine (PHAR 502), 3/1/2023 – Present

Selected Grants

OSF/UIC PGY2 Emergency Medicine Residency, OSF St Anthony., 7/1/2022 - Present, Obligated Amount: $10000; Anticipated Amount: $10000

Selected Publications

Hemenway, Alice N, Kandil, Manar M, MacDowell, Martin. (2021). The Association of Medication Knowledge and Adherence Scores With Hospital Readmission. Hospital Pharmacy, 56, (4), 205-209. doi:10.1177/0018578719883808.

Kandil, Manar, Jaber, Sabrin, Desai, Dharati, Nuñez Cruz, Stephany, Lomotan, Nadine, Ahmad, Uzma, Cirone, Michael, Burkins, Jaxson, McDowell, Marc. (2021). MAGraine: Magnesium compared to conventional therapy for treatment of migraines. The American Journal of Emergency Medicine, 39, 28-33. doi:10.1016/j.ajem.2020.09.033.

Kandil, Manar M, Badowski, Melissa E, Schriever, Christopher A. (2018). Sustained viral suppression with co-administration of oxcarbazepine and dolutegravir. International Journal of STD & AIDS, 29, (8), 831-833. doi:10.1177/0956462417751961.

Education

Degrees:
PharmD, University of Illinois at Chicago, United States, 2018
MS in Biotechnology, University of Alexandria- Institute of Graduate Studies and Research, Egypt, 2013
BS in Biological Sciences, University of Illinois at Chicago, United States, 2007
Associate in Science, Rock Valley College, United States, 2005

Postgraduate Training:
PGY1 Pharmacy Practice Resident, Loyola University Medical Center, United States
PGY2 Emergency Medicine Pharmacy Resident, Advocate Christ Medical Center, United States

Licensures and Certifications

Board Certified Pharmacotherapy Specialist (BCPS), Board of Pharmacy Specialities, 12/1/2020 - 12/1/2027
Board Certified Critical Care Specialist (BCCCP), Board of Pharmacy Specialities, 7/1/2023 - 7/1/2030